BGF

What BGF does

BGF (Business Growth Fund Ltd) is the UK and Ireland's most active growth capital investor, founded in 2011 by major UK banks to address the SME funding gap that emerged after the 2008 financial crisis. The firm provides minority equity investments (typically £3m–£30m) to growth-stage SMEs with £1m–£10m of profit or £3m+ ARR for technology businesses, plus late-seed to Series B funding of £3m–£10m for deep-tech and life sciences spinouts, and cornerstone capital for small-cap quoted companies on AIM and the main market. BGF holds a structural minority stake in every portfolio company — it never takes controlling equity — and pairs capital with board representation, follow-on funding, and access to its Talent Network of non-executive directors and operators.

The firm operates through three core investment products (Growth Stage, Early Stage, Quoted) supported by the Talent Network, the Invest in Women programme (£300m commitment), The Good Growth Podcast, and the BGF Foundation. Since inception BGF has deployed more than £4.7bn across 650+ companies from an evergreen balance sheet of approximately £3bn, supported by a 190+ employee team across 15 regional offices in London, Birmingham, Manchester, Leeds, Newcastle, Edinburgh, Belfast, Cardiff, Bristol, Nottingham, and Dublin. In 2025 the firm returned £600m to investors at a 2x+ money multiple while deploying £416m across 23 new growth investments, 5 early-stage deals, and 45 follow-on rounds.

BGF's revenue mechanics differ from a traditional fund manager: the evergreen structure means returns flow from equity gains on exits (trade sales, IPOs, secondary buyouts) rather than fund management fees, though the firm also explores external fundraises (£500m targeted for 2026). The 2025 landmark £1.5bn sale of OrganOx, plus recent exits including Nonwovenn (8.4x multiple), Optima Partners (4x), Victorian Sliders (3.2x), and Metric Search (4x in 20 months), illustrate the realised-return engine that drives the platform. Certifications include B Corp (score 97.5, Nov 2023), UN PRI signatory since 2020, FCA authorisation (BGF Investment Management Limited, no. 771879), Diversity VC Standard, and the UK government's Investing in Women Code.

Name

BGF

Legal name

Business Growth Fund Limited

Website

https://bgf.co.uk

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

251–500 employees

Short description

BGF (Business Growth Fund) is the UK and Ireland's most active growth capital investor, providing minority equity investments of £3m–£30m to growth-stage SMEs, early-stage deep tech and life sciences companies, and small-cap quoted businesses. Founded in 2011, BGF has deployed over £4.7bn across 650+ portfolio companies from a £3bn evergreen balance sheet.

Ownership category

akta.pro rank

Product category

Growth Capital Investment

NAICS

Portfolio Management and Investment Advice (52394), Portfolio Management and Investment Advice (523940), All Other Financial Investment Activities (52399)

SIC

Investment Advice (6282)

akta.pro primary industry

Business Services (B2B) Growth Equity (FSANACAD)

akta.pro secondary industries

Early-Stage Venture Capital (Series A/B) (FSANAAAB), SME Term Loans & Growth Capital (FSAKAGAB)

Keywords

• Growth capital investment
• Minority equity funding
• Venture capital services
• Private equity funding
• SME growth financing

Headquarters

HQ city

Belfast

HQ country

United Kingdom

HQ region

Europe

Offices11 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Equity Investment Returns: BGF generates returns through minority equity investments in growing companies. Returns are realized through exits via trade sales, IPOs, or secondary share sales. The firm takes minority stakes and does not take controlling equity positions.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

BGF is the UK and Ireland's most active growth capital investor, providing patient minority equity capital to SMEs and early-stage companies. It offers three core investment products: Growth Stage (£3m-£30m for established SMEs with £1m-£10m profit or £3m+ ARR), Early Stage (£3m-£10m for late seed to Series B deep tech and life sciences startups), and Quoted (growth capital for small-cap AIM and main market listed companies). BGF never takes controlling equity and supplements capital with strategic support, board-level talent, and follow-on funding.

Product overview

BGF is the UK and Ireland's most active growth capital investor, offering a platform of investment products designed for businesses at different stages. The core offering consists of three investment products: Growth Stage (for established SMEs seeking £3m-£30m), Early Stage (for late seed to Series B deep tech and life sciences startups seeking £3m-£10m), and Quoted (for small-cap quoted companies). Supporting these are the Invest in Women programme (targeting female-led businesses with £300m commitment), the Talent Network (connecting portfolio companies with board-level talent), and The Good Growth Podcast (educational content resource). BGF takes minority stakes without controlling equity and provides patient capital with flexible follow-on funding and access to extensive networks.

Differentiator

Problem solved

Functional benefit

Brands

• Invest in Women: Initiative committing at least £300 million to female-powered scaleup businesses over five years
• The Good Growth Podcast
• Talent Network
• Quoted

Products and services

• Growth Stage Investment Patient minority equity investment (or mix of equity and debt) for SMEs with ambitious growth plans. Targets established companies typically with £1m-£10m profit or £3m+ ARR for tech, seeking £3m-£30m initial investment. BGF never takes controlling equity and provides follow-on funding, strategic support, and network access throughout the growth journey.
• Early Stage Investment Late seed to Series B funding for deep tech and life sciences startups, typically seeking £3m-£10m from BGF (£5m-£30m total round). Targets science-led innovation companies spinning out from universities or founded by experienced entrepreneurs, focused on breakthrough technologies in health, climate, and advanced tech sectors with IP-protected innovations.
• Quoted Investment

Quantifiable outcome

• Deployed more than £4.7bn across 600+ companies since 2011
• +2 more outcomes

Named customers12 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered core and minor.

• Invest in Women TaskforcecoreStrategic or Co-development Partner · 6 March 2026BGF committed £300m to female-powered businesses over five years as part of the taskforce, addressing the 2% equity funding gap for all-female founding teams.
• Northern GritstoneminorStrategic or Co-development Partner · 27 May 2025Investment company backing science and technology businesses across Northern England, with complementary focus on university spinouts and deeptech.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• LDC (Lloyds Development Capital): UK private equity firm investing in SME management buyouts and growth capital — directly comparable to BGF in geography (UK), check size (£3m–£30m+), and SME focus.
• Foresight Group: Listed UK regional investment manager with growth capital, infrastructure, and PE strategies across UK SMEs — overlaps BGF on UK growth-stage equity and venture/growth funds.
• Maven Capital Partners: UK growth capital and venture investor focused on regional SMEs across the UK — comparable client base, check sizes, and minority-stake approach to BGF.
• YFM Equity Partners: UK SME-focused growth capital and buyout investor — directly comparable to BGF in targeting owner-managed businesses seeking £3m–£25m of growth capital.
• Albion Capital Group: London-based growth capital and venture fund manager with EIS/SEIS/VCT vehicles targeting UK smaller companies — comparable in deploying growth-stage minority capital to ambitious UK entrepreneurs.
• Development Bank of Wales: Welsh government-backed development finance institution providing growth capital and co-investment to Wales-based SMEs — directly comparable co-investor in IQ Endoscopes and other Welsh deals.

Broad incumbents

• Octopus Investments: Large UK investment platform with extensive venture, growth, EIS, and VCT funds targeting UK smaller companies — broader in scope but overlaps on UK SME growth capital and co-invests alongside BGF (Phlux).
• 3i Group: Listed UK private equity firm with growth-stage and infrastructure portfolios — broader and at larger scale than BGF but comparable in UK growth-equity mandate.
• Hg Capital: UK- and European-focused software and services growth investor — overlaps with BGF on UK tech-enabled growth equity and minority-stake value-add.

Emerging players

• Northern Gritstone: Northern England university-spinout and deep-tech investor — comparable to BGF's Early Stage deep-tech and life-sciences product, and a documented co-investment partner (Phlux).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCCHtHuW1EXpEbNdoHmDtM3w
• LinkedInuk.linkedin.com/company/bgfinvestments

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BGF